Industry

Insilico Medicine

Clinical-stage AI drug discovery company developing generative chemistry, target discovery, and foundation models for pharmaceutical research.

Location: Boston, MA
Website
1 model(1 Small molecule, 1 Language model)

Models (1)

MMAI Liquid Foundation Model (LFM2-2.6B-MMAI)

Liquid AI / Insilico Medicine

Released March 3, 2026

A 2.6B-parameter Liquid Foundation Model fine-tuned via Insilico's MMAI Gym to handle ADMET, retrosynthesis, drug-target activity, and molecular optimization in one checkpoint.

Small moleculeLanguage model